These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34471633)

  • 21. Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
    Dintakurti SH; Kamath S; Mahon C; Singh S; Rawal B; Padley SPG; Devaraj A; Price LC; Desai SR; Semple T; Ridge CA
    ERJ Open Res; 2023 Jan; 9(1):. PubMed ID: 36751674
    [No Abstract]   [Full Text] [Related]  

  • 22. Supervised hospital based pulmonary rehabilitation outcome in long COVID-experience from a tertiary care hospital.
    Rao CM; Behera D; Mohapatra AK; Mohapatra SK; Jagaty SK; Banu P; Pattanaik AP; Mohapatra I; Patro S
    J Family Med Prim Care; 2022 Dec; 11(12):7875-7881. PubMed ID: 36994024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supervised pulmonary hypertension exercise rehabilitation (SPHERe): study protocol for a multi-centre randomised controlled trial.
    McGregor G; Bruce J; Ennis S; Mason J; Lall R; Ji C; Sandhu H; Seers K; Banerjee P; Canaway A; Booth K; Taylor SJC; Robertson E; Pincus T; Singh S; Fitzmaurice D; Bowater S; Clift P; Underwood M
    BMC Pulm Med; 2020 May; 20(1):143. PubMed ID: 32429969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CO-FLOW: COvid-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: study protocol of a multicenter prospective cohort study following patients 2 years after hospital discharge.
    Bek LM; Berentschot JC; Hellemons ME; Huijts SM; Aerts JGJV; van Bommel J; van Genderen ME; Gommers DAMPJ; Ribbers GM; Heijenbrok-Kal MH; van den Berg-Emons RJG;
    BMC Health Serv Res; 2021 Aug; 21(1):847. PubMed ID: 34419032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery.
    Obenaus M; Schildgen O; Schürmann D; von Brünneck AC; Janz M; Keller U; Gebauer B; Schilling J; Schwartz S; Weissbrich B; Schneider T; Hofmann J; Mathas S
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 33855064
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19 follow-up planning: what will we be missing?
    Lee L; Iyer S; Jose RJ; Manuel A
    ERJ Open Res; 2020 Apr; 6(2):. PubMed ID: 32494576
    [No Abstract]   [Full Text] [Related]  

  • 27. Additive benefit of rehabilitation on physical status, symptoms and mental health after hospitalisation for severe COVID-19 pneumonia.
    Asimakos A; Spetsioti S; Mavronasou A; Gounopoulos P; Siousioura D; Dima E; Gianniou N; Sigala I; Zakynthinos G; Kotanidou A; Vogiatzis I; Katsaounou P
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37385736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise-based pulmonary rehabilitation for a post-COVID-19 pulmonary fibrosis patient: A case report.
    Choi K; Kim M; Lee SM; Kim J
    Medicine (Baltimore); 2021 Nov; 100(47):e27980. PubMed ID: 34964792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey.
    Belge C; Quarck R; Godinas L; Montani D; Escribano Subias P; Vachiéry JL; Nashat H; Pepke-Zaba J; Humbert M; Delcroix M
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263061
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomised, controlled, open-label pragmatic trial evaluating changes in functional exercise capacity after primary care
    Volckaerts T; Vissers D; Burtin C; Van Meerbeeck X; de Soomer K; Oostveen E; Claes K; Roelant E; Verhaegen I; Thomeer M; Criel M; Quadflieg K; Cops D; Ruttens D; Lapperre TS
    BMJ Open; 2023 Jun; 13(6):e071098. PubMed ID: 37270195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial.
    Dowman LM; May AK; Hill CJ; Bondarenko J; Spencer L; Morris NR; Alison JA; Walsh J; Goh NSL; Corte T; Glaspole I; Chambers DC; McDonald CF; Holland AE
    BMC Pulm Med; 2021 Nov; 21(1):361. PubMed ID: 34758808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits of Cardio-Pulmonary Rehabilitation in Moderate to Severe Forms of COVID-19 Infection.
    Douin C; Forton K; Lamotte M; Gillet A; Van de Borne P
    Healthcare (Basel); 2022 Oct; 10(10):. PubMed ID: 36292491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset.
    Newman J; Boubriak I; Jenkins D; Ng C; Ruggiero A; Screaton N; Cannon J; Toshner M
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34646880
    [No Abstract]   [Full Text] [Related]  

  • 34. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial.
    Greening NJ; Williams JE; Hussain SF; Harvey-Dunstan TC; Bankart MJ; Chaplin EJ; Vincent EE; Chimera R; Morgan MD; Singh SJ; Steiner MC
    BMJ; 2014 Jul; 349():g4315. PubMed ID: 25004917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory Society.
    Takazono T; Mukae H; Izumikawa K; Hasegawa N; Yokoyama A
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34703830
    [No Abstract]   [Full Text] [Related]  

  • 36. Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN' (REGAIN): a structured summary of a study protocol for a randomised controlled trial.
    McGregor G; Sandhu H; Bruce J; Sheehan B; McWilliams D; Yeung J; Jones C; Lara B; Smith J; Ji C; Fairbrother E; Ennis S; Heine P; Alleyne S; Guck J; Padfield E; Potter R; Mason J; Lall R; Seers K; Underwood M
    Trials; 2021 Jan; 22(1):8. PubMed ID: 33407804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19.
    Nieri D; Lenzini G; Canari Venturi B; Celi A
    ERJ Open Res; 2020 Apr; 6(2):. PubMed ID: 32523963
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of COVID-19 shielding on physical activity and quality of life in patients with COPD.
    Hume E; Armstrong M; Manifield J; McNeillie L; Chambers F; Wakenshaw L; Burns G; Heslop Marshall K; Vogiatzis I
    Breathe (Sheff); 2020 Sep; 16(3):200231. PubMed ID: 33447283
    [No Abstract]   [Full Text] [Related]  

  • 39. Interview with Prof. Dr Richard Casaburi, Presidential Awardee 2020.
    Troosters T; Casaburi R
    Breathe (Sheff); 2020 Dec; 16(4):200249. PubMed ID: 33447296
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneity.
    Milanese M; Anselmo M; Buscaglia S; Garra L; Goretti R; Parodi L; Riccio G; Tassara R; Gnerre P
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34285908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.